Lataa...
Nrf2 Signaling Pathway in Chemoprotection and Doxorubicin Resistance: Potential Application in Drug Discovery
Doxorubicin (DOX) is extensively applied in cancer therapy due to its efficacy in suppressing cancer progression and inducing apoptosis. After its discovery, this chemotherapeutic agent has been frequently used for cancer therapy, leading to chemoresistance. Due to dose-dependent toxicity, high conc...
Tallennettuna:
| Julkaisussa: | Antioxidants (Basel) |
|---|---|
| Päätekijät: | , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7996755/ https://ncbi.nlm.nih.gov/pubmed/33652780 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10030349 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|